TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T11211	Androgen receptor	D0L4FS	Genistein	Phase 2	5280961	C15H10O5	270.24	C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O	IC50 = 1300000 nM	Non binder
T11211	Androgen receptor	B1HML3	4-(4-Hydroxyphenyl)-2-butanone	Investigative	21648	C10H12O2	164.2	CC(=O)CCC1=CC=C(C=C1)O	IC50 = 251188.64 nM	Non binder
T11211	Androgen receptor	B1RXW4	3-[2-(2-m-Tolyloxy-ethylsulfanyl)-benzoimidazol-1-yl]-propionic acid	Investigative	2772726	C19H20N2O3S	356.4	CC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CCC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B1Z7RO	3-[2-(2-p-Tolyloxy-ethylsulfanyl)-benzoimidazol-1-yl]-propionic acid	Investigative	2857621	C19H20N2O3S	356.4	CC1=CC=C(C=C1)OCCSC2=NC3=CC=CC=C3N2CCC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B2T5YB	2-(3-Phenoxypropyl)-1H-benzimidazole	Investigative	4529791	C16H16N2O	252.31	C1=CC=C(C=C1)OCCCC2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B3JEM6	Ethyl (2-{[2-(3,5-dimethylphenoxy)ethyl]thio}-1H-benzimidazol-1-yl)acetate	Investigative	23613764	C21H24N2O3S	384.5	CCOC(=O)CN1C2=CC=CC=C2N=C1SCCOC3=CC(=CC(=C3)C)C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B48ORV	[2-(1-Prop-2-enylbenzimidazol-2-ylthio)ethoxy]benzene	Investigative	17027902	C18H18N2OS	310.4	C=CCN1C2=CC=CC=C2N=C1SCCOC3=CC=CC=C3	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B4PR7F	2-((3-Phenoxypropyl)thio)-1H-benzo[d]imidazole	Investigative	1653625	C16H16N2OS	284.4	C1=CC=C(C=C1)OCCCSC2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B81WUX	4-Hydroxyphenylacetone	Investigative	7019274	C9H10O2	150.17	CC(=O)CC1=CC=C(C=C1)O	IC50 = 416869.38 nM	Non binder
T11211	Androgen receptor	B8EPJ1	2-{2-[2-(3-Methylphenoxy)ethylthio]benzimidazolyl}-1-morpholin-4-ylethan-1-one	Investigative	16016075	C22H25N3O3S	411.5	CC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)N4CCOCC4	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B9HN3S	2-[2-[2-(3-Tert-butylphenoxy)ethylsulfanyl]benzimidazol-1-yl]acetic acid	Investigative	71719211	C21H24N2O3S	384.5	CC(C)(C)C1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B9PGZ8	Methyl 2-[2-[2-(3-ethylphenoxy)ethylsulfanyl]benzimidazol-1-yl]acetate	Investigative	71717987	C20H22N2O3S	370.5	CCC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)OC	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	B9UI6G	Methyl 2-[2-[2-(3-prop-2-enylphenoxy)ethylsulfanyl]benzimidazol-1-yl]acetate	Investigative	71719212	C21H22N2O3S	382.5	COC(=O)CN1C2=CC=CC=C2N=C1SCCOC3=CC=CC(=C3)CC=C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BA85LV	3-[2-[2-(3-Ethylphenoxy)ethylsulfanyl]benzimidazol-1-yl]propanoic acid	Investigative	71717985	C20H22N2O3S	370.5	CCC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CCC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BAW74T	2-(2-Phenoxyethylsulfonyl)-1H-benzimidazole	Investigative	576549	C15H14N2O3S	302.4	C1=CC=C(C=C1)OCCS(=O)(=O)C2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BBD45T	N-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]aniline	Investigative	12607025	C15H15N3S	269.4	C1=CC=C(C=C1)NCCSC2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BC82DA	2-(2-Phenoxyethylsulfinyl)-1H-benzimidazole	Investigative	71562914	C15H14N2O2S	286.4	C1=CC=C(C=C1)OCCS(=O)C2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BCN3L0	2-[2-[2-(3-Ethylphenoxy)ethylsulfanyl]benzimidazol-1-yl]acetic acid	Investigative	71720428	C19H20N2O3S	356.4	CCC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BDC90W	2-{2-[2-(2,5-Dimethylphenoxy)ethylthio]benzimidazolyl}acetic acid	Investigative	17027949	C19H20N2O3S	356.4	CC1=CC(=C(C=C1)C)OCCSC2=NC3=CC=CC=C3N2CC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BFCL19	2-[2-(2-Phenoxyethylthio)benzimidazolyl]ethan-1-ol	Investigative	2772508	C17H18N2O2S	314.4	C1=CC=C(C=C1)OCCSC2=NC3=CC=CC=C3N2CCO	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BH3W6Z	[2-(2-m-Tolyloxy-ethylsulfanyl)-benzoimidazol-1-yl]-acetic acid	Investigative	2772715	C18H18N2O3S	342.4	CC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BIE1B5	2-(2-Phenoxyethylsulfanyl)-1,3-benzoxazole	Investigative	2258754	C15H13NO2S	271.3	C1=CC=C(C=C1)OCCSC2=NC3=CC=CC=C3O2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BJ6R3D	2-[2-[2-(3,4-Dimethylphenoxy)ethylsulfanyl]benzimidazol-1-yl]acetic acid	Investigative	2772716	C19H20N2O3S	356.4	CC1=C(C=C(C=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)O)C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BJK61Q	Methyl 2-{2-[2-(3,4-dimethylphenoxy)ethylthio]benzimidazolyl}acetate	Investigative	17027986	C20H22N2O3S	370.5	CC1=C(C=C(C=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)OC)C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BJN7K6	2-[2-(3-Methylphenoxy)ethylsulfanyl]-1-(2-phenoxyethyl)benzimidazole	Investigative	71720429	C24H24N2O2S	404.5	CC1=CC(=CC=C1)OCCSC2=NC3=CC=CC=C3N2CCOC4=CC=CC=C4	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BN0L2R	3-[2-(2-Phenoxy-ethylsulfanyl)-benzoimidazol-1-yl]-propionic acid	Investigative	2772722	C18H18N2O3S	342.4	C1=CC=C(C=C1)OCCSC2=NC3=CC=CC=C3N2CCC(=O)O	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BN7DQ6	N,N-Diethyl-2-{2-[2-(3-methylphenoxy)ethylthio]benzimidazolyl}acetamide	Investigative	17028050	C22H27N3O2S	397.5	CCN(CC)C(=O)CN1C2=CC=CC=C2N=C1SCCOC3=CC=CC(=C3)C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BQ6Z5C	N-(2-Phenoxyethyl)-1H-benzimidazol-2-amine	Investigative	55023552	C15H15N3O	253.3	C1=CC=C(C=C1)OCCNC2=NC3=CC=CC=C3N2	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	BZ1R4P	2-{2-[2-(3,5-Dimethylphenoxy)ethylthio]benzimidazolyl}acetic acid	Investigative	17028025	C19H20N2O3S	356.4	CC1=CC(=CC(=C1)OCCSC2=NC3=CC=CC=C3N2CC(=O)O)C	IC50 > 200000 nM	Non binder
T11211	Androgen receptor	D0S9YX	biochanin A	Investigative	5280373	C16H12O5	284.26	COC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O	IC50 = 1600000 nM	Non binder